Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies.
Cimen AN, Torabfam GC, Tok YT, Yucebag E, Arslan N, Saribal D, Esken G, Dogan O, Kuskucu MA, Mete B, Aygun G, Tabak F, Can F, Ergonul O, Midilli K, Kutlu O, Cetinel S.
Cimen AN, et al. Among authors: kutlu o.
Bioanalysis. 2024;16(21-22):1167-1177. doi: 10.1080/17576180.2024.2411920. Epub 2024 Oct 16.
Bioanalysis. 2024.
PMID: 39411978